Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

THE TCW trial has demonstrated that fractional flow reserve (FFR)-guided percutaneous PCI plus TAVI is superior to SAVR plus ...

African American patients that receive PCI for LMCA disease have increased risk for postdischarge bleeding compared with ...

The following is a summary of “Left ventricular systolic function after percutaneous coronary intervention: patterns of ...

Korea: The FLASH Trial has revealed that artificial intelligence-based fully automated quantitative coronary angiography ...

A local hospital has again earned an accreditation for a crucial nonsurgical heart procedure. Chan Soon-Shiong Medical Center ...

Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few ...

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) ...

The following is a summary of “Early and Long-term Outcomes of Patients with Acute Coronary Syndrome Undergoing Percutaneous ...

Blood thinners are essential medications for many people who have undergone a procedure called percutaneous coronary ...

Inclacumab is a monoclonal antibody commercialized by Pfizer, with a leading Phase III program in Sickle Cell Disease With Vaso-Occlusive Crisis.

CureGene Pharmaceutical ('CureGene'), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...